Stock-Based Compensation - Options, RSAs, RSUs and MSUs Activity (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 30, 2017	Dec. 31, 2016	Jan. 02, 2016
Summary of stock-based payment and stock option values
Weighted-average period of recognition of unrecognized compensation costs	2 years
Cash received for the issuance of common stock, net of shares withheld for taxes	$ 11,800
Amount of withheld taxes paid	$ 15,800
Stock options
Stock options activity
Outstanding at the beginning of the year (in shares)	228
Exercised (in shares)	(58)
Outstanding at the end of the year (in shares)	170	228
Vested and expected to vest at the end of the year (in shares)	120
Exercisable at the end of the year (in shares)	40
Weighted-Average Exercise Price
Outstanding at the beginning of the year (in dollars per share)	$ 37.95
Exercised (in dollars per share)	35.27
Outstanding at the end of the year (in dollars per share)	38.88	$ 37.95
Vested and expected to vest at the end of the year (in dollars per share)	40.39
Exercisable at the end of the year (in dollars per share)	$ 33.98
Weighted-Average Remaining Contractual Term (In years)
Outstanding at the end of the year	7 years 6 months
Vested and expected to vest at the end of the year	8 years 1 month 6 days
Exercisable at the end of the year	5 years 3 months 18 days
Aggregate Intrinsic Value
Outstanding at the end of the year (in dollars)	$ 8,387
Vested and expected to vest at the end of the year (in dollars)	5,744
Options exercisable at the end of the year (in dollars)	2,173
Weighted-Average Purchase Price
Per grant (in dollars per share)		40.38
Weighted-average grant date fair value
Per grant (in dollars per share)		$ 40.38
Summary of stock-based payment and stock option values
Intrinsic value of stock options exercised	$ 2,174	$ 2,560	$ 6,612
RSAs and RSUs
Summary of restricted stock awards and restricted stock units
Outstanding at the beginning the of year (in shares)	1,689
Granted (in shares)	625
Vested, earned or issued (in shares)	(726)
Cancelled or forfeited (in shares)	(65)
Outstanding at the end of the year (in shares)	1,523	1,689
Outstanding at the end of the year and expected to vest (in shares)	1,430
Weighted-Average Purchase Price
Per grant (in dollars per share)	$ 72.85	$ 40.55	$ 49.14
Weighted-Average Remaining Vesting Term
Outstanding at the end of year	10 months 24 days
Outstanding at the end of year and expected to vest	10 months 24 days
Aggregate Intrinsic Value
Outstanding at the end of the year (in dollars)	$ 134,534
Outstanding at the end of the year and expected to vest (in dollars)	$ 126,228
Weighted-average grant date fair value
Per grant (in dollars per share)	$ 72.85	$ 40.55	$ 49.14
Summary of stock-based payment and stock option values
Intrinsic value	$ 53,093	$ 36,502	$ 45,298
Grant date fair value	$ 32,449	$ 39,853	$ 41,072
PSUs and MSUs
Summary of restricted stock awards and restricted stock units
Outstanding at the beginning the of year (in shares)	229
Granted (in shares)	107
Vested, earned or issued (in shares)	(11)
Cancelled or forfeited (in shares)	(66)
Outstanding at the end of the year (in shares)	259	229
Outstanding at the end of the year and expected to vest (in shares)	242
Weighted-Average Purchase Price
Per grant (in dollars per share)	$ 78.40	$ 32.23	$ 48.36
Weighted-Average Remaining Vesting Term
Outstanding at the end of year	1 year 3 months 18 days
Outstanding at the end of year and expected to vest	1 year 3 months 18 days
Aggregate Intrinsic Value
Outstanding at the end of the year (in dollars)	$ 22,911
Outstanding at the end of the year and expected to vest (in dollars)	$ 21,388
Weighted-average grant date fair value
Per grant (in dollars per share)	$ 78.40	$ 32.23	$ 48.36
Summary of stock-based payment and stock option values
Intrinsic value	$ 687
Grant date fair value	$ 633